Results of treatment of myofascial pain syndrome using apparatus-punctural anti-pain therapy

Likhachev S.A.; Mironov S.A.

doi:https://doi.org/10.17116/pain20222001121

Likhachev S.A.

Republican Research and Clinical Center of Neurology and Neurosurgery

Mironov S.A.

Verkhnedvinsk Central District Hospital

Results of treatment of myofascial pain syndrome using apparatus-punctural anti-pain therapy

Authors:

Likhachev S.A., Mironov S.A.

More about the authors

Journal: Russian Journal of Pain. 2022;20(1): 21‑26

DOI: 10.17116/pain20222001121

Read: 4993 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Likhachev SA, Mironov SA. Results of treatment of myofascial pain syndrome using apparatus-punctural anti-pain therapy. Russian Journal of Pain. 2022;20(1):21‑26. (In Russ.)
https://doi.org/10.17116/pain20222001121

Подписка 2025 Российский журнал боли (Russian Journal of Pain)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Myofascial pain syndrome (MFPS) is a multifactorial disease. In order to expose it to the patient during examination, the doctor needs to pay attention not only to the data of anamnesis, complaints and neurological examination, but also to the data of manual muscle testing. The trigger points and painful muscle cords found during its use in the affected muscles confirm this diagnosis, and also allows us to purposefully use our treatment method to effectively eliminate pain syndrome.

OBJECTIVE

To evaluate the results of treatment of patients with MFPS with the use of apparatus-punctural anti-pain therapy (APP therapy), carried out through the administration of Midocalm drugs using the PPA-01 device.

MATERIAL AND METHODS

Between November 2020 and October 2021 51 people were recruited into the study (29 women (57%), 22 men (43%)) with MFPS of various localization. We used: manual muscle testing, digital pain rating scale, Oswestry quality of Life questionnaire, McGill pain questionnaire, estesiometric study, thermographic study.

RESULTS

It was found that the most common is the MFPS of the muscles of the lumbar localization — 55%, then the cervical — 37% and the thoracic — 8% of the number of patients examined. An algorithm has been developed for the selection of the zone of influence in case of MFPS of various localization, which allows to influence TP in all interested muscles. The study revealed a decrease in pain intensity, thresholds of tactile and pain sensitivity, and an improvement in the quality of life in almost all treated patients (94%).

CONCLUSION

The use of APP therapy in the treatment of MFPS of various localization will increase the effectiveness of treatment, improve the quality of life of patients and reduce the duration of treatment.

Keywords:

myofascial pain syndrome

APP therapy

Authors:

Likhachev S.A.

Republican Research and Clinical Center of Neurology and Neurosurgery

Mironov S.A.

Verkhnedvinsk Central District Hospital

Received:

16.12.2022

Accepted:

24.12.2022

Close metadata

References:

Kukushkin ML, Khitrov NK. Obshchaya pathologya boli. M.: Meditsina; 2004. (In Russ.).
Godzenko AA, Badokin VV. Lokal’naya terapya myofastsial’nogo bolevogo syndroma. RMZh. Rheumatologya. 2007;26:1998-2003. (In Russ.).
Likhachev SA, Mironov SA, Murzo EA. Treatment of Myofascial Pain Syndrome with the Help of Semi-Automatic Analgesic Device «PPA-01». Nevrologiya i nejrokhirurgiya. Vostochnaya Evropa. 2021;11(2):145-155. (In Russ.).
Cherepanov EA. Russkaya versiya oprosnika Oswestry: kul’turnaya adaptatsiya i validnost’. Khirurgiya pozvonochnika. 2009;3:093-098. (In Russ.).
Shkaly, testy i oprosniki v meditsinskoj reabilitatsii: rukovodstvo dlya vrachej i nauchnykh rabotnikov. Belova A.N., Shchepetova O.N. M.: Antidor; 2002;439. (In Russ.).
Likhachev SA, Mironov SA. Lechebno-diagnosticheskaya posledovatelnost’ pri miofastsial’nom bolevom syndrome. Retsenziruemyj sbornik nauchnykh trudov «Actual’nye voprosy nevrologii i nejrokhirurgii». 2021;24:130-141. (In Russ.).
Mironov SA, Lichachev SA, Murzo EA. Zayavka na patent №2021/EA/0006 ot 22.01.02. Sposob lecheniya miofastsial’nogo bolevogo sindroma. (In Russ.).
Patent US8029527B2-01 the United States of America, A61B 17/34. Device for local skin puncture. Applicant Lisek V.; patent holder MT Derm GMbH, application 24.01.05, published 04.10.2011. (In English).
Travell JG, Simons DG. Myofascial Pain and Dysfunction. 1989;864. (In Russ.).
Shirokov VA. Myofastsialnyj bolevoj syndrom: problemy diagnostiki i lecheniya. Effektivnaya farmakoterapiya. 2017;21:22-28. (In Russ.). https://umedp.ru/articles/miofastsialnyy_bolevoy_sindrom_problemy_diagnostiki_i_lecheniya.html
Shirokov VA, Yun OP, Bakhtereva EV. Efficiency local injection therapy with preparation Mydocalm in myophacialis painful syndromes cervicobrachial region. S.S. Korsakov Journal of Neurology and Psychiatry. 2009;109:78-81. (In Russ.). https://elibrary.ru/item.asp?id=13123780
Mironov SA, Likhachev SA, Murzo EA. The First Experience of Treatment of Myofascial Pain Syndrome Using the Semi-Automatic Analgesic Device “PPA-01”. Nevrologiya i nejrokhirurgiya. Vostochnaya Evropa. 2021;11(2):156-166. (In Russ.).